EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Real-World Observational Analysis of Clinical Characteristics and Treatment Patterns of Patients with Chronic Sialorrhea

Michael A Hast, Amanda M Kong iD, Jenna Abdelhadi, Rohan Shah iD, Andrew Szendrey, Jordan Holmes

Toxins · 2024

DOI: 10.3390/toxins16080366 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Toxins, 2024. Verfasst von Michael A Hast und 5 weiteren Autor:innen. Beteiligte Einrichtung: Merz Therapeutics, Raleigh, NC 27615, USA. Hauptthemen laut MEDLINE: Sialorrhea, Botulinum Toxins, Type A. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merz (Germany), Merz Therapeutics GmbH, Frankfurt am Main, Germany.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic sialorrhea is a condition characterized by excessive drooling, often associated with neurological and neuromuscular disorders such as Parkinson’s disease, cerebral palsy, and stroke. Despite its prevalence, it remains underdiagnosed and poorly understood, leading to a lack of comprehensive data on patient demographics, clinical characteristics, and treatment patterns. This study aimed to help fill these existing gaps by analyzing real-world data using Optum’s de-identified Clinformatics® Data Mart Database. Patients were required to have a diagnosis indicative of sialorrhea plus evidence of sialorrhea treatment between 1/1/2007 and 5/31/2022. Two cohorts were analyzed: patients with evidence of newly diagnosed sialorrhea and associated treatment, and sialorrhea patients initiating incobotulinumtoxinA. Clinical characteristics, comorbidities, symptoms, and treatment utilization were described before and after diagnosis and incobotulinumtoxinA initiation. No formal statistical comparisons were performed. Patients were predominantly aged 65 or older, male, and non-Hispanic white. Parkinson’s disease and cerebral palsy were the most common comorbidities among adults and children, respectively. Treatment patterns suggest that anticholinergics are more commonly used than botulinum toxin therapy. The findings offer valuable information for improving diagnosis and treatment approaches and suggest a need for further research into treatment effectiveness, safety, and disease burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SialorrheaBotulinum Toxins, Type AHumansMaleFemaleAgedMiddle AgedAdultChronic DiseaseChildAdolescentCholinergic AntagonistsYoung AdultAged, 80 and overChild, PreschoolParkinson DiseaseComorbidity

Stichwörter der Autor:innen

Parkinson’santicholinergicbotulinum toxincerebral palsyneurologic disorderssialorrheatreatment utilization

Substanzen

Botulinum Toxins, Type ACholinergic AntagonistsincobotulinumtoxinA

Autor:innen und Institutionen

  • Merz Therapeutics, Raleigh, NC 27615, USA.
  • Aetion, New York, NY 10001, USA.

ORCID-Profile: Amanda M Kong, Rohan Shah

Förderung

  • Merz (Germany)
  • Merz Therapeutics GmbH, Frankfurt am Main, Germany

Zitieren

APA

Hast, M. A., Kong, A. M., Abdelhadi, J., Shah, R., Szendrey, A., & Holmes, J. (2024). Real-World Observational Analysis of Clinical Characteristics and Treatment Patterns of Patients with Chronic Sialorrhea. Toxins. https://doi.org/10.3390/toxins16080366

Vancouver

Hast MA, Kong AM, Abdelhadi J, Shah R, Szendrey A, Holmes J. Real-World Observational Analysis of Clinical Characteristics and Treatment Patterns of Patients with Chronic Sialorrhea. Toxins. 2024. doi:10.3390/toxins16080366

BibTeX
@article{Hast2024,
  author = {Hast, Michael A and Kong, Amanda M and Abdelhadi, Jenna and Shah, Rohan and Szendrey, Andrew and Holmes, Jordan},
  title = {Real-World Observational Analysis of Clinical Characteristics and Treatment Patterns of Patients with Chronic Sialorrhea},
  journal = {Toxins},
  year = {2024},
  doi = {10.3390/toxins16080366}
}
Kostenlos starten →